Molecular Templates, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Net Loss Per Common Share

Net Loss Per Common Share

3 Months Ended

Mar. 31, 2018

NOTE 2 — NET LOSS PER COMMON SHARE

Basic net loss per common share is computed by dividing net loss by the weighted-average number of common shares outstanding during the period. Diluted net loss per share is computed by giving effect to all potential dilutive common shares, including outstanding options and warrants. The following is the calculation of basic and diluted net loss per share (in thousands, except share and per share data):

	Three Months Ended March 31,
	2018		2017
Numerator:
Net loss attributable to common shareholders	$	8,714	$	1,622
Denominator:
Weighted average common shares outstanding - basic and diluted		26,989,693		214,641
Net loss per share:
Basic and diluted	$	0.32	$	7.56

The following outstanding warrants and options were excluded from the computation of diluted net loss per share for the periods presented because including them would have had an antidilutive effect (in thousands):

	Three Months Ended March 31,
	2018		2017
Shares issuable upon exercise of warrants		3,522		35
Shares issuable upon exercise of stock options		2,880		458